Update on drug-eluting coronary stents (Q36266053)

13 August 2017

1 reference

title

Update on drug-eluting coronary stents (English)

1 reference

13 August 2017

4

Gregg W Stone

1 reference

13 August 2017

5

Jeffrey W Moses

1 reference

13 August 2017

3

Martin B Leon

1 reference

13 August 2017

2

Mykola V Tsapenko

1 reference

13 August 2017

1

Nicholas N Kipshidze

1 reference

13 August 2017

publication date

1 September 2005

1 reference

Expert Review of Cardiovascular Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

3

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

953-968

1 reference

13 August 2017

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

The effect of completeness of revascularization on event-free survival at one year in the ARTS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

In-hospital mortality associated with the use of intra-aortic balloon counterpulsation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Magnitude of left atrial V wave is the determinant of exercise capacity in patients with mitral stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Using the risk of restenosis as a guide to triaging patients between surgical and percutaneous coronary revascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Empirical assessment of the impact of drug-eluting stents on the rate of use of coronary revascularization procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

The use of drug eluting stents in single and multivessel disease: results from a single centre experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registrie

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Hybrid coronary revascularization in the era of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Effect of amiodarone on the plasma levels of metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Placement of coronary stents in bifurcation lesions by the "culotte" technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Drug-eluting stents for coronary bifurcations: insights into the crush technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Stent thrombosis after successful sirolimus-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Angiographic patterns of restenosis after paclitaxel-eluting stent implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Clinical experiences using everolimus-eluting stents in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Drug-eluting bioabsorbable magnesium stent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary Article

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.5.953

21 January 2018

Identifiers

DOI

10.1586/14779072.3.5.953

1 reference

13 August 2017

1 reference